RecruitingPhase 2NCT03400826
Effects of Simvastatin on Uterine Leiomyoma Size
A Double-blinded, Phase II, Randomized Control Trial to Study the Effects of Simvastatin in Patients With Uterine Leiomyoma
Sponsor
Johns Hopkins University
Enrollment
60 participants
Start Date
Aug 20, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
The study aims to study the effect of simvastatin on the size of uterine fibroids.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 55 Years
Inclusion Criteria19
- Signed informed written consent.
- Gender: female.
- Age: 18-55 years at time of signing consent.
- BMI of subjects: \< 45 kg/m2.
- Uterine fibroids:
- Diagnosed by ultrasound (MRI will be used only if ultrasound is inconclusive).
- Number: any number of fibroids.
- Location: submucosal or intramural.
- At least one fibroid of diameter \> 3cm.
- Symptoms: one or more of the following symptoms of heavy menstrual bleeding (HMB), defined as: Experienced cyclic (22 to 35 days) abnormal uterine bleeding (heavy or prolonged) in at least 3 of the last 6 menstrual periods, including menstrual bleeding lasting 5 or more days or heavy bleeding per participant recall. Examples of heavy bleeding may include, but are not limited to the following:
- Requires the use of double protection to manage menstrual bleeding.
- Menstrual bleeding accompanied by the sensation of "gushing" or "flooding".
- Saturates more than 1 tampon or sanitary pad per hour for 3 or more consecutive hours.
- Regularly needs to change the tampon or sanitary pad at night or regularly soils bedclothes.
- Heavy bleeding that affects work, school, or social activities.
- Pelvic pain/ pressure likely caused by fibroids.
- Plan for surgery (hysterectomy or myomectomy).
- Normal Pap smear within the last year.
- Use of contraception during study such as non-hormonal oral contraceptives, intrauterine devices (IUD)/ intrauterine systems (IUS), barrier contraceptives, abstinence or sterilization.
Exclusion Criteria17
- Pregnancy or lactation.
- Previous or current uterine, cervical or ovarian cancer.
- Current endometrial hyperplasia or history of atypical endometrial hyperplasia. Endometrial biopsy will be done during screening (if not done within last 12 months).
- Suspicion of leiomyosarcoma.
- Recent rapid growth of fibroids (i.e. doubling in size within 1-6 months period).
- Unevaluated gynecologic abnormalities (unexplained vaginal bleeding, cervical dysplasia, or abnormal adnexal/ovarian mass).
- Menopausal status.
- Surgery is urgently indicated (\< 3 months) for medical or social reasons.
- Hemoglobin ≤ 6 g/dL.
- Currently enrolled in another investigational study.
- Mental condition or other barrier preventing informed written consent.
- Allergy or hypersensitivity to simvastatin.
- Current use of simvastatin or other drugs of the same class.
- Concomitant administration of strong CYP3A4 inhibitors including itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone, and cobicistat-containing products.
- Concomitant administration of gemfibrozil, cyclosporine, or danazol, verapamil, diltiazem, amiodarone, diltiazem, dronedarone, amlodipine, ranolazine, lomitapide, and grapefruit juice.
- Active liver disease, which may include unexplained persistent elevations in hepatic transaminase levels.( elevation of aspartate transaminase and/or alanine transaminase \> 2 s.d. above the normal range at screening visit)
- Known increased risk or diagnosis of a myopathy.
Interventions
DRUGSimvastatin 40mg
The Treatment Group subjects will orally intake encapsulated Simvastatin 40 mg tablets daily for the 12 weeks duration with water in the evening.
DRUGPlacebo 40 mg
The Placebo group will orally intake encapsulated Starch 1500, 40 mg Placebo for 12 weeks duration with water in the evening.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03400826
Related Trials
Prescription of Letrozole for Uterine Myoma
NCT061436315 locations
The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription.
NCT065365172 locations
Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
NCT061358701 location
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
NCT070786821 location
Comparison of Operative Hysteroscopy Performed in the Operating Room Versus Outpatient Settings
NCT071466591 location